{"id":"https://openalex.org/W4387433485","doi":"https://doi.org/10.1210/jendso/bvad114.112","title":"SAT664 Obesity And Overweight Diagnosis, Physician Prescription And Patient Filling Of Anti-Obesity Medications In US","display_name":"SAT664 Obesity And Overweight Diagnosis, Physician Prescription And Patient Filling Of Anti-Obesity Medications In US","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387433485","doi":"https://doi.org/10.1210/jendso/bvad114.112"},"language":"en","primary_location":{"id":"doi:10.1210/jendso/bvad114.112","doi":"https://doi.org/10.1210/jendso/bvad114.112","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1210/jendso/bvad114.112","pdf_url":"https://academic.oup.com/jes/article-pdf/7/Supplement_1/bvad114.112/51901741/bvad114.112.pdf","source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/jes/article-pdf/7/Supplement_1/bvad114.112/51901741/bvad114.112.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087377005","display_name":"Kyrian Ezendu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyrian Ezendu","raw_affiliation_strings":["Eli Lilly & Company , Indianapolis, IN , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company , Indianapolis, IN , USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075196493","display_name":"Casey Choong","orcid":"https://orcid.org/0000-0001-6476-784X","observed_orcids":["https://orcid.org/0000-0001-6476-784X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Casey Kar-Chan Choong","raw_affiliation_strings":["Eli Lilly & Company , Indianapolis, IN , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company , Indianapolis, IN , USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102579608","display_name":"Madeline Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madeline Brown","raw_affiliation_strings":["Eli Lilly & Company , Indianapolis, IN , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company , Indianapolis, IN , USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012989716","display_name":"Raleigh Malik","orcid":"https://orcid.org/0000-0002-2797-3545","observed_orcids":["https://orcid.org/0000-0002-2797-3545"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raleigh Malik","raw_affiliation_strings":["Eli Lilly & Company , Indianapolis, IN , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company , Indianapolis, IN , USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053784299","display_name":"Emily R. Hankosky","orcid":"https://orcid.org/0000-0001-9934-584X","observed_orcids":["https://orcid.org/0000-0001-9934-584X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily R Hankosky","raw_affiliation_strings":["Eli Lilly & Company , Indianapolis, IN , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company , Indianapolis, IN , USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":3100,"currency":"USD","value_usd":3100},"apc_paid":{"value":3100,"currency":"USD","value_usd":3100},"fwci":0.4656,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.60040397,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"7","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10010","display_name":"Obesity, Physical Activity, Diet","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12066","display_name":"Obesity and Health Practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8579999804496765},{"id":"https://openalex.org/keywords/overweight","display_name":"overweight","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-obesity-drugs","display_name":"anti-obesity drugs","score":0.9860000014305115},{"id":"https://openalex.org/keywords/physician-prescribing","display_name":"physician prescribing","score":0.46700000762939453},{"id":"https://openalex.org/keywords/obesity-related-complications","display_name":"obesity complications","score":0.8379999995231628},{"id":"https://openalex.org/keywords/phentermine-topiramate","display_name":"phentermine/topiramate","score":0.9279999732971191},{"id":"https://openalex.org/keywords/lorcaserin","display_name":"lorcaserin","score":0.9039999842643738},{"id":"https://openalex.org/keywords/orlistat","display_name":"orlistat","score":0.9890000224113464},{"id":"https://openalex.org/keywords/naltrexone-bupropion","display_name":"naltrexone/bupropion","score":0.9990000128746033},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/icd-10-diagnoses","display_name":"ICD-10 diagnoses","score":0.609000027179718},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.6320000290870667},{"id":"https://openalex.org/keywords/pharmacy-claims-data","display_name":"pharmacy claims data","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.7972723841667175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7518696784973145},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.6044832468032837},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.5756338834762573},{"id":"https://openalex.org/C2778456266","wikidata":"https://www.wikidata.org/wiki/Q418157","display_name":"Phentermine","level":4,"score":0.5274933576583862},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4172517955303192},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36450380086898804},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3351094126701355},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.3117230534553528},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.14175352454185486}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1210/jendso/bvad114.112","doi":"https://doi.org/10.1210/jendso/bvad114.112","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1210/jendso/bvad114.112","pdf_url":"https://academic.oup.com/jes/article-pdf/7/Supplement_1/bvad114.112/51901741/bvad114.112.pdf","source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10555360","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10555360","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10555360/pdf/bvad114.112.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Endocr Soc","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1210/jendso/bvad114.112","doi":"https://doi.org/10.1210/jendso/bvad114.112","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1210/jendso/bvad114.112","pdf_url":"https://academic.oup.com/jes/article-pdf/7/Supplement_1/bvad114.112/51901741/bvad114.112.pdf","source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387433485.pdf","grobid_xml":"https://content.openalex.org/works/W4387433485.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3182614457","https://openalex.org/W4405608171","https://openalex.org/W4389944962","https://openalex.org/W3216771289","https://openalex.org/W4403720959","https://openalex.org/W2042962131","https://openalex.org/W4367674314","https://openalex.org/W3209628414","https://openalex.org/W7008787823","https://openalex.org/W3133741628"],"abstract_inverted_index":{"Abstract":[0],"Disclosure:":[1],"K.":[2],"Ezendu:":[3],"Employee;":[4,12,27,35,50],"Self;":[5,13,20,28,36,43,51,58],"Eli":[6,14,21,29,37,44,52,59],"Lilly":[7,15,22,30,38,45,53,60],"&":[8,16,23,31,39,46,54,61],"Company.":[9,17,24,32,40,47,55,62],"C.K.":[10],"Choong:":[11],"Stock":[18,41,56],"Owner;":[19,42,57],"M.":[25],"Brown:":[26],"R.":[33],"Malik:":[34],"E.R.":[48],"Hankosky:":[49],"Background:":[63],"The":[64,224,284,297,325,350,454,491],"prevalence":[65],"of":[66,89,120,197,229,244,251,437],"obesity":[67,90,98,147,200,298,415,441,456,498,508],"and":[68,72,83,99,106,166,180,237,294,321,346,386,394,401,416,446,457,473,497],"overweight":[69,92,100,159,185,202,326,417,458,496],"is":[70,499],"high":[71],"growing":[73],"in":[74,81,110,188,207,220,254,268,304,308,314,319,323,332,336,344,348,374,378,412,429,464,469,482],"the":[75,195,208,242,255,311,339,366,384,430],"US":[76],"adult":[77],"population.":[78],"Current":[79],"trends":[80],"diagnosis":[82,101,186,219,299,312,327,418,445],"treatment":[84],"with":[85,146,158,199,247,310,338,440,478],"anti-obesity":[86],"medications":[87],"(AOMs)":[88],"or":[91,156,184,201,222,226,257,487],"are":[93],"unknown.":[94],"Objectives:":[95],"To":[96],"describe":[97],"rates,":[102,105],"AOM":[103,107,253,262,471,489],"prescribing":[104,225,351,385,472],"fill":[108,227,367,387],"rates":[109,187,368,388,419],"AOM-eligible":[111,121,140,245,279,484],"adults":[112,122,145,157,198,280,485],"from":[113,127,136,302,330,358,372],"2016":[114,137,305,320,333,345,375,381],"to":[115,138,277,306,334,360,376,382,399,405,504],"2021.":[116,139,324,349,379],"Methods:":[117],"Separate":[118],"cohorts":[119,285],"(18-80":[123],"years)":[124],"were":[125,142,192,274,460],"constructed":[126],"Optum\u2019s":[128],"de-identified":[129],"Market":[130],"Clarity":[131],"Data":[132],"for":[133,289,353,369,389,495,507],"each":[134,189,269,282],"year":[135],"individuals":[141],"defined":[143],"as":[144,194,241],"(\u22651":[148,160],"body":[149],"mass":[150],"index":[151],"(BMI)":[152],"value":[153],"\u226530":[154],"kg/m2)":[155,165],"BMI":[161,206],"27":[162],"-":[163],"<30":[164],"\u22651":[167],"obesity-related":[168],"complication":[169],"(ORC)":[170],"including":[171],"type":[172],"2":[173],"diabetes,":[174],"hypertension,":[175],"obstructive":[176],"sleep":[177],"apnea,":[178],"dyslipidemia,":[179],"cardiovascular":[181],"diseases.":[182],"Obesity":[183],"cohort":[190],"(2016-2021)":[191],"determined":[193,204,240],"percentage":[196,243],"(as":[203],"by":[205],"electronic":[209],"health":[210],"record":[211],"(EHR)),":[212],"respectively,":[213],"who":[214],"had":[215,286],"a":[216,248,423,451,467],"corresponding":[217],"ICD-10":[218],"claims":[221,267,315],"EHR.":[223],"rate":[228,300,313,328,341,352],"AOMs":[230,354,370,391],"(i.e.,":[231,392],"phentermine-topiramate,":[232],"lorcaserin,":[233],"orlistat,":[234],"naltrexone-bupropion,":[235],"liraglutide,":[236],"semaglutide)":[238,395],"was":[239,355],"members":[246],"written":[249],"prescription":[250,263],"an":[252,443],"EHR":[256],"at":[258,317,342],"least":[259],"one":[260],"filled":[261],"based":[264],"on":[265],"pharmacy":[266],"year,":[270,433],"respectively.":[271,407],"Results:":[272],"There":[273],"between":[275],"1,606,593":[276],"2,277,415":[278],"constituting":[281],"cohort.":[283],"similar":[287],"distributions":[288],"age,":[290],"gender,":[291],"race,":[292],"BMI,":[293],"insurance":[295],"type.":[296],"increased":[301],"39.4%":[303],"57.2%":[307],"2021,":[309,337,383],"only":[316],"33.5%":[318],"47.3%":[322],"rose":[329,371],"18.1%":[331],"31.2%":[335],"claims-based":[340,452],"15.4%":[343],"29.2%":[347],"low,":[356,421,477],"ranging":[357],"0.4%":[359,373],"0.5%":[361],"across":[362],"all":[363],"years.":[364],"Similarly,":[365],"0.6%":[377],"From":[380],"incretin":[390],"liraglutide":[393],"doubled":[396],"(from":[397,403],"0.1%":[398,404],"0.2%)":[400],"quadrupled":[402],"0.4%),":[406],"Conclusions:":[408],"Despite":[409],"some":[410],"increases":[411],"recent":[413,432],"years,":[414],"remain":[420],"suggesting":[422],"significant":[424],"clinical":[425,492],"care":[426,493],"gap.":[427],"Even":[428],"most":[431],"less":[434,447,479],"than":[435,448,462,480],"3":[436],"5":[438],"people":[439],"received":[442,450],"official":[444],"half":[449],"diagnosis.":[453],"overall":[455],"diagnoses":[459],"higher":[461],"reported":[463],"claims,":[465],"signaling":[466],"gap":[468,494],"reimbursement.":[470],"filling":[474,488],"remained":[475],"consistently":[476],"7":[481],"1000":[483],"receiving":[486],"prescriptions.":[490],"substantial,":[500],"needing":[501],"effective":[502],"measures":[503],"reduce":[505],"barriers":[506],"care.":[509],"Presentation:":[510],"Saturday,":[511],"June":[512],"17,":[513],"2023":[514]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-10-09T00:00:00"}